{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus", "item": "https://www.patentleaderboard.com/patent/6153199"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus

Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus

US Patent 6153199 · Granted Nov 28, 2000

Estimated economic value: $770,593,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2025
Modified Marek's disease virus, and vaccines made therefrom2025
Modified Marek's disease virus, and vaccines made therefrom2022
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2022
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2020
Reassortant BTV and AHSV vaccines2020
Methods for freeze-drying and rehydrating biologics2020
Antibiotic-free plasmid2019
FMDV and E2 fusion proteins and uses thereof2019
Newcastle disease virus vectored avian vaccines2019
Hendra virus recombinant compositions and uses thereof2019
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2019